TC BioPharm (Holdings) PLC (TCBP)
0.61
-0.02
(-3.14%)
USD |
NASDAQ |
Nov 22, 12:51
TC BioPharm Total Liabilities (Quarterly): 7.807M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 7.807M |
| June 30, 2023 | 7.848M |
| December 31, 2022 | 13.26M |
| June 30, 2022 | 15.23M |
| Date | Value |
|---|---|
| December 31, 2021 | 33.18M |
| September 30, 2021 | 26.58M |
| December 31, 2020 | 14.46M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.807M
Minimum
Mar 2024
33.18M
Maximum
Dec 2021
16.91M
Average
14.46M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 237.45M |
| Biodexa Pharmaceuticals PLC | 6.628M |
| Verona Pharma PLC | 251.33M |
| NuCana PLC | 20.58M |
| Autolus Therapeutics PLC | 350.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.171M |
| Shareholders Equity (Quarterly) | 1.364M |